[Federal Register Volume 62, Number 22 (Monday, February 3, 1997)]
[Presidential Documents]
[Pages 5137-5138]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-2818]
[[Page 5135]]
_______________________________________________________________________
Part IV
The President
_______________________________________________________________________
Executive Order 13034--Extension of Presidential Advisory Committee on
Gulf War Veterans' Illnesses
Presidential Documents
Federal Register / Vol. 62, No. 22 / Monday, February 3, 1997 /
Presidential Documents
___________________________________________________________________
Title 3--
The President
[[Page 5137]]
Executive Order 13034 of January 30, 1997
Extension of Presidential Advisory Committee on
Gulf War Veterans' Illnesses
By the authority vested in me as President by the
Constitution and the laws of the United States of
America, it is hereby ordered as follows:
Section 1. Extension. The Presidential Advisory
Committee on Gulf War Veterans' Illnesses (the
``Committee''), established pursuant to Executive Order
12961 of May 26, 1995, is hereby extended for the
purposes set forth herein. All provisions of that order
relating to membership and administration shall remain
in effect. All Committee appointments, as well as the
President's designation of a Chairperson, shall remain
in effect. The limitations set forth in section 2(c)-
(e) and section 4(a) of Executive Order 12961 shall
also remain in effect. The Committee shall remain
subject to the Federal Advisory Committee Act, as
amended, 5 U.S.C. App. 2.
Sec. 2. Functions. (a) The Committee shall report to
the President through the Secretary of Defense, the
Secretary of Veterans Affairs, and the Secretary of
Health and Human Services.
(b) The Committee shall have two principal roles:
(1) Oversight of the ongoing investigation being
conducted by the Department of Defense with the
assistance, as appropriate, of other executive
departments and agencies into possible chemical or
biological warfare agent exposures during the Gulf War;
and
(2) Evaluation of the Federal Government's plan
for and progress towards the implementation of the
Committee's recommendations contained in its Final
Report submitted on December 31, 1996.
(c) The Committee shall provide advice and
recommendations related to its oversight and evaluation
responsibilities.
(d) The Committee may also provide additional
advice and recommendations prompted by any new
developments related to its original functions as set
forth in section 2(b) of Executive Order 12961.
(e) The Committee shall submit by letter a status
report by April 30, 1997, and a final supplemental
report by October 31, 1997, unless otherwise directed
by the President.
[[Page 5138]]
Sec. 3. General Provisions. (a) The Committee shall
terminate 30 days after submitting its final
supplemental report.
(b) This order is intended only to improve the
internal management of the executive branch and it is
not intended to create any right, benefit or trust
responsibility, substantive or procedural, enforceable
at law or equity by a party against the United States,
its agencies, its officers, or any person.
(Presidential Sig.)
THE WHITE HOUSE,
January 30, 1997.
[FR Doc. 97-2818
Filed 1-31-97; 10:55 am]
Billing code 3195-01-P
